Get started
Author

Chelsae R Watters

Observed names: Chelsae R. Watters, Chelsae Watters
ORCID: 0000-0001-6916-6509
Observed ORCID: 0000-0001-6916-6509
OpenAlex ID: A5035239041
Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcoma
2023 · Chelsae R. Watters, Oumar Barro, et al. · Molecular Therapy — Oncolytics · 9
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade
2024 · Mulu Z. Tesfay, Yuguo Zhang, et al. · Molecular Therapy Oncology · 5
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
2025 · Chelsae R. Watters, Oumar Barro, et al. · Molecular Therapy Oncology · 3
Repeat Systemic Delivery of Cross-Neutralization Resistant Synthetic Vesiculoviruses Immunomodulates the Tumor Microenvironment
2025 · Natalie M Elliott, Benjamin L Kendall, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Enhanced Genomic Stability in Monomorphic Post-Transplant Lymphoproliferative Disorders Is Driven By Distinct Mechanisms Stratified By EBV Status
2023 · Lindsey Armitage, Sarah Gibson, et al. · Blood · 1
Peptide occupancy governs HLA-E checkpoint interactions enabling VISTA recognition of destabilized HLA-E conformers
2026 · Chelsae R. Watters, Soroush Ghaffari, et al. · Communications Biology
845 HLA-E interacts with VISTA in a peptide-dependent manner
2024 · Chelsae R Watters, Soroush Ghaffari, et al. · Regular and Young Investigator Award Abstracts
Works count: 7
Citation count: 19
H-index: 3
I10-index:
Year
Topic
Type